Rest Of Asia Pacific Non Invasive Prenatal Testing Market (2024-2029)
The Rest Of Asia Pacific Non Invasive Prenatal Testing Market was valued at $78 Million in 2024 and projected to reach to $152.7 Million by 2029, representing a compound annual growth rate of 14.4%. Rest Of Asia Pacific's NIPT market is positioned for substantial growth, expanding from $78.0 million in 2024 to $152.7 million by 2029.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Asia Pacific Non Invasive Prenatal Testing Market Trends and Insights
- Rest Of Asia Pacific demonstrates strong market momentum driven by increasing maternal age, rising awareness of prenatal screening benefits, and improving healthcare infrastructure across emerging economies.
- The region's growth trajectory reflects expanding access to advanced diagnostic technologies and growing adoption among both healthcare providers and expectant parents seeking safer, non-invasive testing alternatives. Rest Of Asia Pacific's 14.4% compound annual growth rate underscores the region's significant potential within the broader Asia Pacific prenatal testing landscape.
- Key drivers include rising disposable incomes, expanding private healthcare sectors, and government initiatives promoting maternal health screening programs.
- Rest Of Asia Pacific is witnessing accelerated demand from urban centers where healthcare awareness and affordability of NIPT services are improving.
- The forecast period through 2029 positions Rest Of Asia Pacific as a critical growth engine, with emerging markets in the region increasingly adopting advanced prenatal diagnostic solutions..
Key Market Statistics
- CAGR (2024-2029) 14.4% CAGR
- Market Size, 2024 ~USD 78 Million
- Forecast, 2029 ~USD 152.7 Million
- Country Rest Of Asia Pacific
Rest Of Asia Pacific Non Invasive Prenatal Testing Market Overview
Rapid Market Expansion :
Rest Of Asia Pacific's NIPT market is growing at 14.4% CAGR, nearly matching the global rate of 14.5%, demonstrating strong regional adoption and market maturation in emerging economies across the region.
Increasing Maternal Age Trends :
Rising maternal age in Rest Of Asia Pacific countries is driving demand for advanced prenatal screening solutions, as older pregnancies carry higher chromosomal abnormality risks, making NIPT adoption critical.
Healthcare Infrastructure Improvements :
Emerging economies in Rest Of Asia Pacific are investing heavily in diagnostic infrastructure and healthcare accessibility, enabling wider NIPT adoption beyond major metropolitan centers and tier-1 cities.
Growing Awareness and Acceptance :
Increasing maternal education and healthcare provider advocacy in Rest Of Asia Pacific are driving prenatal screening awareness, with NIPT gaining acceptance as a standard-of-care diagnostic option.
Rest Of Asia Pacific Non Invasive Prenatal Testing Market Dynamics
- This doubling of market value reflects accelerating adoption driven by demographic shifts, improved healthcare accessibility, and rising consumer awareness of prenatal screening benefits across emerging economies in the region. The region's growth trajectory is supported by increasing healthcare expenditure, expanding diagnostic laboratory networks, and growing physician adoption of NIPT protocols.
- As healthcare systems in Rest Of Asia Pacific countries continue modernizing and maternal healthcare becomes a priority, NIPT is expected to transition from premium services in developed urban centers to mainstream offerings across diverse healthcare settings..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- Rest Of Asia Pacific's NIPT market is valued at $78.0 million in 2024 and expected to nearly double to $152.7 million by 2029, reflecting strong regional demand.
- The 14.4% CAGR in Rest Of Asia Pacific indicates accelerating adoption of non-invasive prenatal testing across emerging healthcare systems.
- Rest Of Asia Pacific's growth is fueled by rising maternal age, increasing healthcare awareness, and expanding private diagnostic sector investments.
- Rest Of Asia Pacific represents a high-potential market segment within Asia Pacific, driven by improving economic conditions and maternal health prioritization.
Non Invasive Prenatal Testing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | CFDNA IN MATERNAL PLASMA (Method) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 14.5% from 2024 to 2029 |
| Largest Segment | TRISOMY (Application) |
| Market Size Base Year (Billions) | ~USD 7.16 (2024) |
| Revenue Forecast (Billions) | ~USD 14.1 (2029) |
| Segments Covered | Product & Service, Type, Method, Application, End User |
Rest Of Asia Pacific Non Invasive Prenatal Testing Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Products
- Services
By Type
- Assay Kits & Reagents
- Consumables
- Disposables
- Instruments
- Microarrays
- Ngs Systems
- Other Instruments
- Pcr Instruments
- Ultrasound Devices
By Method
- Biochemical Screening Tests
- Cfdna In Maternal Plasma
- Cfdna In Maternal Plasma Tests
- Ultrasound Detection
By Application
- Microdeletion Syndrome
- Other Applications
- Trisomy
By End User
- Diagnostic Laboratories
- Hospitals
Target Audience
- Diagnostic Device Manufacturers : NIPT platform and reagent manufacturers need Rest Of Asia Pacific-specific market data to prioritize regional expansion, allocate R&D resources, and develop localized product strategies for emerging economies.
- Healthcare Providers & Laboratories : Diagnostic laboratories and prenatal care centers in Rest Of Asia Pacific require market insights to justify NIPT service investments, benchmark against regional competitors, and plan capacity expansion.
- Investment & Private Equity Firms : Investors evaluating healthcare opportunities in Rest Of Asia Pacific need detailed market forecasts and growth drivers to assess NIPT sector attractiveness and identify acquisition or funding targets.
- Healthcare Consultants & Advisors : Management consulting firms advising healthcare clients in Rest Of Asia Pacific require regional market data to support strategic planning, market entry analysis, and competitive positioning recommendations.
- Government & Healthcare Policy Bodies : Healthcare regulators and policy makers in Rest Of Asia Pacific countries need market intelligence to inform prenatal screening guidelines, reimbursement policies, and healthcare infrastructure investment decisions.
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuation data specific to Rest Of Asia Pacific ($78.0M in 2024, $152.7M by 2029) with country-level breakdowns to support accurate business planning and investment decisions in the region.
- Growth Driver Analysis : Understand region-specific growth catalysts including maternal age demographics, healthcare infrastructure development, and awareness trends unique to Rest Of Asia Pacific emerging economies to identify market opportunities.
- Competitive Landscape Intelligence : Gain insights into Rest Of Asia Pacific-specific competitive dynamics, market consolidation patterns, and key player strategies tailored to regional healthcare systems and regulatory environments.
- Market Entry & Expansion Strategy : Develop targeted go-to-market strategies for Rest Of Asia Pacific by understanding regional adoption barriers, healthcare provider preferences, and reimbursement landscapes across different country segments.
- Investment & Partnership Opportunities : Identify high-potential markets within Rest Of Asia Pacific for partnerships, acquisitions, and expansion based on growth rates, healthcare infrastructure readiness, and emerging market dynamics.
Frequently asked questions
What is the current market size of NIPT in Rest Of Asia Pacific?
Rest Of Asia Pacific's Non Invasive Prenatal Testing market was valued at $78.0 million in 2024.
What is the projected market size for Rest Of Asia Pacific by 2029?
Rest Of Asia Pacific's NIPT market is forecasted to reach $152.7 million by 2029.
What is the growth rate for NIPT in Rest Of Asia Pacific?
Rest Of Asia Pacific is experiencing a compound annual growth rate of 14.4% from 2024 to 2029.
What factors are driving NIPT market growth in Rest Of Asia Pacific?
Rest Of Asia Pacific's growth is driven by increasing maternal age, rising healthcare awareness, improving infrastructure, expanding private sectors, and government maternal health initiatives.
How does Rest Of Asia Pacific compare to the global NIPT market?
Rest Of Asia Pacific's 14.4% CAGR is comparable to the global rate of 14.5%, positioning the region as a key growth contributor to the worldwide prenatal testing market.
RESEARCH METHODOLOGY
This study involved four major activities in estimating the current non-invasive prenatal testing (NIPT) market size. Extensive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the value market. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the non-invasive prenatal testing (NIPT) market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include CEOs, consultants, subject-matter experts, directors, general managers, developers, and other key opinion leaders of the various companies that offer non-invasive prenatal testing (NIPT) product and service. Primary sources from the demand side include industry experts such as doctors, hospital directors and managers, and other medical professionals.
Primary research was conducted to identify segmentation types; industry trends; technology trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, and key player strategies.
Note 1: Others include sales, marketing, and product managers.
Note 2: Their total revenues define the tiers of companies as of 2023, tier 1 = >USD 500 million, tier 2 = USD 200 million to USD 500 million, and tier 3 = <USD 200 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the non-invasive prenatal testing (NIPT) market was arrived at after data triangulation from four different approaches, as mentioned below.
Bottom-up Approach: Revenues of individual companies were gathered from public sources and databases. Shares of the medical device cleaning businesses of leading players were gathered from secondary sources to the extent available. In certain cases, the share of the business unit was ascertained after a detailed analysis of various parameters, including product portfolio, market positioning, selling price, and geographic reach and strength. Individual shares or revenue estimates were validated through expert interviews.
Country level Analysis: The size of the non-invasive prenatal testing (NIPT) market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of non-invasive prenatal testing (NIPT) products in the overall non-invasive prenatal testing (NIPT) market was obtained from secondary data and validated by primary participants to arrive at the total non-invasive prenatal testing (NIPT) market. Primary participants further validated the numbers.
Primary Interviews: As a part of the primary research process, individual respondent insights on the market size and growth were taken during the interview (regional and global, as applicable). All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.
Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall non-invasive prenatal testing (NIPT) market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
After complete market engineering with calculations for market statistics, market size estimations, market forecasting, market breakdown, and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods to perform market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and further quantitative analysis was also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Global Non-invasive prenatal testing (NIPT) market Size: Top-Down Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Global Non-invasive prenatal testing (NIPT) market Size: Bottom-Up Approach
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable.
Approach to derive the market size and estimate market growth
The market rankings for leading players were ascertained after a detailed assessment of their revenues from the non-invasive prenatal testing (NIPT) business using secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases, the revenue share was arrived at after a detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with industry experts.
Market Definition
Non-invasive prenatal testing (NIPT) is a method used to screen chromosomal abnormalities in a developing fetus by analyzing small fragments of fetal Cell-Free DNA circulating in a pregnant woman's blood. Non-invasive prenatal tests enable the detection of chromosomal abnormalities, such as trisomy 21 (Down Syndrome), trisomy 18 (Edwards' Syndrome), trisomy 13 (Patau Syndrome), microdeletion syndrome, and other genetic conditions. This market encompasses products such as assay kits and reagents, next generation sequencing systems, and diagnostic services offered by laboratories.
Key Stakeholders
- Non-invasive prenatal testing product manufacturing companies
- Hospitals and private clinics
- Diagnostic laboratories
- Medical research institutes
- Market research and consulting firms
- Suppliers and distributors of NIPT instruments
- Venture capitalists and investors
- Regulatory agencies and government bodies
Objectives of the Study
- To define, describe, and forecast the global non-invasive prenatal testing (NIPT) market on the basis of product and service, method, application, end user, and region
- To provide detailed information about the key factors influencing the market growth, such as drivers, restraints, opportunities, challenges, and industry trends
- To strategically analyze the regulatory scenario, pricing trends, value chain, supply chain, ecosystem analysis, key stakeholders and buying criteria, technology scenario, patent scenario, and key conferences and events in the market
- To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the overall udder health market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
- To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies.
- To strategically analyze the udder health market in five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
- To track and analyze competitive developments such as acquisitions, partnerships, and expansions in the udder health market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific non-invasive prenatal testing (NIPT) market into China, Japan, India, South Korea, and other countries.
Get the Full Non Invasive Prenatal Testing Market Report
Full forecast, segment splits, and company analysis for all Non Invasive Prenatal Testing Market.
- Canada Non Invasive Prenatal Testing Market
- US Non Invasive Prenatal Testing Market
- UK Non Invasive Prenatal Testing Market
- Germany Non Invasive Prenatal Testing Market
- France Non Invasive Prenatal Testing Market
- Italy Non Invasive Prenatal Testing Market
- Spain Non Invasive Prenatal Testing Market
- Japan Non Invasive Prenatal Testing Market
- China Non Invasive Prenatal Testing Market
- India Non Invasive Prenatal Testing Market
- Australia Non Invasive Prenatal Testing Market
- South Korea Non Invasive Prenatal Testing Market
- Brazil Non Invasive Prenatal Testing Market
- Mexico Non Invasive Prenatal Testing Market
- Rest Of Europe Non Invasive Prenatal Testing Market
- Rest Of Latin America Non Invasive Prenatal Testing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
